In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 26 for your search:
Drug:  folic acid
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Prevention
Status: Completed
Age: 20 to 65
Sponsor: NCI, Other
Protocol IDs: AAAC8618, R01CA133595, NCT01050556

2.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: DERMATUX, NCT01315990

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: AIO-KRK-0207, ML21768, EudraCT-Nr.: 2008-007974-39, NCT00973609

4.

Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-91173, NCI-V92-0026

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CAM201, NCT00291785

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PDX-009, NCT00481871

7.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TULA-T064031, USO-01103, NCT00033722

8.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 6 months to 65 years
Sponsor:
Protocol IDs: EUC-47491, NCI-V92-0171

9.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: ONCO-021-98S, NCT00018551

10.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: HOG GU03-67, NCT00216099

11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9732, H3E-MC-S077, NCT00330915

12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PDX-008, 2006-002811-29, NCT00364923

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000579360, UAB-F060511015, UAB-IRB0000196, F060511015, NCT00703196

14.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 11652, H3E-CR-S111, NCT00609518

15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PDX-015, NCT00998946

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PDX-014, 2008-006425-14, NCT01118624

17.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 10-112, NCT01183065

18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: HANSOH20090601, NCT01194453

19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: UOSG-AMC-0804, NCT01490437

20.

Phase: Phase I
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0005068, TULA-T3004, NCI-G01-2017, NCT00024310

21.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 40 to 72
Sponsor: NCI, Other
Protocol IDs: CDR0000393455, P30CA016056, RUH-PHO-0514-0404, RPCI-EPR-20703, AECM-0401022E, NEMCH-6060, NCT00096330

22.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 40 to 72
Sponsor: NCI
Protocol IDs: RUH-PHO-0514-0306, PHO-0514-0306, NCT00611000

23.

Phase: No phase specified
Type: Prevention
Status: Closed
Age: 75 and under
Sponsor: Other
Protocol IDs: QMC-UKCAP, EU-20045, NCT00033319

24.

Phase: No phase specified
Type: Prevention
Status: Closed
Age: adult
Sponsor: NCI
Protocol IDs: SWOG-8745, NCI-P89-0007

25.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: Under 75
Sponsor: NCI
Protocol IDs: BWH-1999-P-001674/10, 1999-P-001674/10, BWH-94-06819, NCT00512850
1   
New Search